Anika Therapeutics (ANIK) Current Deferred Tax Assets: 2010-2015
Historic Current Deferred Tax Assets for Anika Therapeutics (ANIK) over the last 5 years, with Sep 2015 value amounting to $1.4 million.
- Anika Therapeutics' Current Deferred Tax Assets rose 113.85% to $1.4 million in Q3 2015 from the same period last year, while for Sep 2015 it was $1.4 million, marking a year-over-year increase of 113.85%. This contributed to the annual value of $1.2 million for FY2014, which is 80.38% up from last year.
- Anika Therapeutics' Current Deferred Tax Assets amounted to $1.4 million in Q3 2015, which was down 3.46% from $1.5 million recorded in Q2 2015.
- Anika Therapeutics' Current Deferred Tax Assets' 5-year high stood at $2.0 million during Q4 2012, with a 5-year trough of $659,040 in Q4 2013.
- For the 3-year period, Anika Therapeutics' Current Deferred Tax Assets averaged around $1.3 million, with its median value being $1.4 million (2015).
- In the last 5 years, Anika Therapeutics' Current Deferred Tax Assets slumped by 67.56% in 2013 and then soared by 125.76% in 2015.
- Anika Therapeutics' Current Deferred Tax Assets (Quarterly) stood at $1.9 million in 2011, then climbed by 5.87% to $2.0 million in 2012, then crashed by 67.56% to $659,040 in 2013, then surged by 80.38% to $1.2 million in 2014, then skyrocketed by 113.85% to $1.4 million in 2015.
- Its Current Deferred Tax Assets was $1.4 million in Q3 2015, compared to $1.5 million in Q2 2015 and $1.5 million in Q1 2015.